{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:21:13Z","timestamp":1778152873964,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"crossref","award":["BCRF-17-050"],"award-info":[{"award-number":["BCRF-17-050"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10549-019-05316-7","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T18:35:27Z","timestamp":1560537327000},"page":"641-649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Talking about risk in the context of genomic tests (TARGET): development and evaluation of an educational program for clinicians"],"prefix":"10.1007","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0577-4518","authenticated-orcid":false,"given":"L.","family":"Fallowfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1264-1396","authenticated-orcid":false,"given":"I.","family":"Solis-Trapala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1947-018X","authenticated-orcid":false,"given":"R.","family":"Starkings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9898-2289","authenticated-orcid":false,"given":"S.","family":"Catt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3167-9891","authenticated-orcid":false,"given":"S.","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8939-0081","authenticated-orcid":false,"given":"V.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,14]]},"reference":[{"issue":"1","key":"5316_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pec.2011.02.004","volume":"86","author":"B Chewning","year":"2012","unstructured":"Chewning B, Bylund CL, Shah B, Arora NK, Gueguen JA, Makoul G (2012) Patient preferences for shared decisions: a systematic review. Patient Educ Couns 86(1):9\u201318","journal-title":"Patient Educ Couns"},{"key":"5316_CR2","unstructured":"Department for Business Innovation and Skills. The 2011 skills for life survey: a survey of literacy, numeracy and ICT levels in England. BIS Research paper number 81. London: Department for Business Innovation and Skills, 2012. https:\/\/www.gov.uk\/government\/publications\/2011-skills-for-life-survey accessed Feb 25th 2019"},{"issue":"635","key":"5316_CR3","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.3399\/bjgp15X685285","volume":"65","author":"G Rowlands","year":"2015","unstructured":"Rowlands G, Protheroe J, Winkley J et al (2015) A mismatch between population health literacy and the complexity of health information: an observational study. Br J Gen Pract 65(635):e379\u2013e386","journal-title":"Br J Gen Pract"},{"issue":"10","key":"5316_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/jnci\/87.10.720","volume":"87","author":"WC Black","year":"1995","unstructured":"Black WC, Nease RF, Tosteson ANA (1995) Perceptions of breast cancer risk and screening effectiveness in women younger than 50\u00a0years of age. JNCI 87(10):720\u2013731","journal-title":"JNCI"},{"issue":"2","key":"5316_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1055-9965.EPI-06-0525","volume":"16","author":"SE Lillie","year":"2007","unstructured":"Lillie SE, Brewer NT, O\u2019Neill SC et al (2007) Retention and use of breast cancer recurrence risk information from genomic tests: the role of health literacy. Cancer Epidemiol Biomark Prev 16(2):249\u2013254","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"5316_CR6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/0272989X09360371","volume":"30","author":"IM Lipkus","year":"2010","unstructured":"Lipkus IM, Peters E, Kimmick G et al (2010) Breast cancer patients\u2019 treatment expectations after exposure to the decision aid program adjuvant online: the influence of numeracy. Med Decis Mak 30(4):464\u2013473","journal-title":"Med Decis Mak"},{"key":"5316_CR7","unstructured":"NHS Predict V2.1 www.predict.nhs.uk\/index.html ; Accessed Feb 25, 2019"},{"key":"5316_CR8","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/cncr.24990","volume":"116","author":"JP Tzeng","year":"2010","unstructured":"Tzeng JP, Mayer D, Richman AR, Lipkus I, Han PK, Valle CG, Carey LA, Brewer NT (2010) Women\u2019s experiences with genomic testing for breast cancer recurrence risk. Cancer 116:1992\u20132000","journal-title":"Cancer"},{"key":"5316_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10549-011-1791-9","volume":"133","author":"NT Brewer","year":"2012","unstructured":"Brewer NT, Richman AR, DeFrank JT et al (2012) Breast Cancer Res Treat 133:553\u2013561","journal-title":"Breast Cancer Res Treat"},{"key":"5316_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jbtep.2015.12.004","volume":"51","author":"RN Carleton","year":"2016","unstructured":"Carleton RN, Duranceau S, Shulman EP et al (2016) Self-reported intolerance of uncertainty and behavioural decisions. J Behav Ther Exp Psychiatry 51:58\u201365","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"7","key":"5316_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/ACM.0b013e31821da915","volume":"86","author":"VP Luther","year":"2011","unstructured":"Luther VP, Crandall SJ (2011) Commentary: ambiguity and uncertainty: neglected elements of medical education curricula? Acad Med 86(7):799\u2013800","journal-title":"Acad Med"},{"key":"5316_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pec.2009.10.030","volume":"80","author":"MC Politi","year":"2010","unstructured":"Politi MC, Legare\u00b4 F (2010) Physicians\u2019 reactions to uncertainty in the context of shared decision making. Patient Educ Couns 80:155\u2013157","journal-title":"Patient Educ Couns"},{"issue":"5","key":"5316_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0277-9536(90)90098-D","volume":"31","author":"G Geller","year":"1990","unstructured":"Geller G, Faden R, Levine DM (1990) Tolerance for ambiguity among medical students: implications for their selection, training and practice. Soc Sci Med 31(5):619\u2013624","journal-title":"Soc Sci Med"},{"key":"5316_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0140-6736(02)07810-8","volume":"359","author":"L Fallowfield","year":"2002","unstructured":"Fallowfield L, Jenkins V, Farewell V et al (2002) Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial. Lancet 359:650\u2013656","journal-title":"Lancet"},{"key":"5316_CR15","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/sj.bjc.6601309","volume":"89","author":"L Fallowfield","year":"2003","unstructured":"Fallowfield L, Jenkins V, Farewell V et al (2003) Enduring impact of communication skills training: results of a 12-month follow-up. BJC 89:1445\u20131449","journal-title":"BJC"},{"issue":"3","key":"5316_CR16","first-page":"765","volume":"20","author":"V Jenkins","year":"2002","unstructured":"Jenkins V, Fallowfield L (2002) Can communication skills training alter physicians\u2019 beliefs and behaviour in clinics? JCO 20(3):765\u2013769","journal-title":"JCO"},{"key":"5316_CR17","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1136\/bmj.38366.562685.8F","volume":"330","author":"V Jenkins","year":"2005","unstructured":"Jenkins V, Fallowfield L, Solis-Trapala I et al (2005) Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme. BMJ 330:400","journal-title":"BMJ"},{"key":"5316_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1634\/theoncologist.2011-0271","volume":"17","author":"LJ Fallowfield","year":"2012","unstructured":"Fallowfield LJ, Solis-Trapala I, Jenkins VA (2012) Evaluation of an educational program to improve communication with patients about early phase trial participation. Oncologist 17:377\u2013383","journal-title":"Oncologist"},{"issue":"105","key":"5316_CR19","first-page":"107","volume":"21","author":"RN Carleton","year":"2007","unstructured":"Carleton RN, Norton MAP, Asmundson GJG (2007) Fearing the unknown: a short version of the Intolerance of Uncertainty Scale. J Anxiety Disord 21(105):107\u2013117","journal-title":"J Anxiety Disord"},{"issue":"11","key":"5316_CR20","doi-asserted-by":"publisher","first-page":"966","DOI":"10.7326\/0003-4819-127-11-199712010-00003","volume":"127","author":"LM Schwartz","year":"1997","unstructured":"Schwartz LM, Woloshin S, Black WC, Welch HG (1997) The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med 127(11):966\u2013972","journal-title":"Ann Intern Med"},{"key":"5316_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2307\/2983471","volume":"159","author":"RJ Cook","year":"1996","unstructured":"Cook RJ, Farewell VT (1996) Multiplicity considerations in the design and analysis of clinical trials. J R Stat Soc 159:93\u2013110","journal-title":"J R Stat Soc"},{"key":"5316_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/00401706.1965.10490250","volume":"7","author":"DR Cox","year":"1965","unstructured":"Cox DR (1965) A remark on multiple comparison methods. Technometrics 7:223\u2013224","journal-title":"Technometrics"},{"key":"5316_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF02294802","volume":"68","author":"SR Lipsitz","year":"2003","unstructured":"Lipsitz SR, Parzen M, Fitzmaurice GM et al (2003) A two-stage logistic regression model for analysing inter-rater agreement. Psychometrika 68:289\u2013298","journal-title":"Psychometrika"},{"issue":"2","key":"5316_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1539-6053.2008.00033.x","volume":"8","author":"G Gigerenzer","year":"2007","unstructured":"Gigerenzer G, Gaissmaier W, Kurz-Milcke E et al (2007) Helping doctors and patients make sense of health statistics. Psychol Sci Public Interest 8(2):53\u201396","journal-title":"Psychol Sci Public Interest"},{"issue":"1","key":"5316_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/0272989X0102100105","volume":"21","author":"IM Lipkus","year":"2001","unstructured":"Lipkus IM, Samsa G, Rimer BK (2001) General performance on a numeracy scale among highly educated samples. Med Decis Mak 21(1):37\u201344","journal-title":"Med Decis Mak"},{"issue":"1","key":"5316_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S1930297500004952","volume":"9","author":"S Ghazal","year":"2014","unstructured":"Ghazal S, Cokely ET, Garcia-Retamero R (2014) Predicting biases in very highly educated samples: numeracy and metacognition. Judgm Decis Mak 9(1):15\u201334","journal-title":"Judgm Decis Mak"},{"key":"5316_CR27","unstructured":"Royal College of Anesthetists. https:\/\/www.rcoa.ac.uk\/patientinfo\/risk-and-probability . Accessed Mar 12, 2019"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05316-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T13:13:07Z","timestamp":1694956387000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05316-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,14]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["5316"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05316-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,14]]},"assertion":[{"value":"3 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"LJF has received research grants from Bristol Myers Squibb, and from Novartis. LJF has received speaker honorarium from Amgen, TEVA, Voluntis, Oncolia, Pfizer, Eisai and Genomic Health and had a consultancy role with Puma Biotechnology, Roche, Eisai, Voluntis, AstraZeneca and Takeda. VAJ has received research grants from Aventis Pharma trading as Sanofi. All other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (ref: ER\/RMLS21\/1). The datasets during and\/or analysed during the current study are available from the corresponding author on reasonable request","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}